Business description: DocMorris AG

Zur Rose Group AG is a Switzerland-based company engaged in the drug distribution sector. The Company focuses on the wholesale trade of medicines, as well as operation of a mail-order pharmacy. The Company's activities are divided into two business segments: Zur Rose and DocMorris. The Zur Rose division includes wholesale business and provides drugs to medical doctors, health insurance companies, hospitals and healthcare companies, among others. The DocMorris division manages the mail-order business for drug retail. The Company operates in Switzerland, Germany and the Netherlands through a number of subsidiaries, such as Zur Rose Suisse AG, Zur Rose Pharma GmbH, BlueCare AG, DocMorris NV, Eurapon Pharmahandel GmbH and Vitalsana BV.

Number of employees: 1,337

Sales by Activity: DocMorris AG

Fiscal Period: December 2021 (CHF) 2022 (CHF) 2023 (CHF) 2024 (CHF) 2025 (CHF)

Germany

1.02B 859M 907M 954M 1.06B

Europe

81.94M 70.45M 62.08M 63.1M 63.12M

Eliminations

-6.99M -7.52M - - -

Switzerland

627M 687M - - -

Geographical breakdown of sales: DocMorris AG

Fiscal Period: December 2021 (CHF) 2022 (CHF) 2023 (CHF) 2024 (CHF) 2025 (CHF)

Germany

1.02B 859M 907M 954M 1.06B

Other

81.88M 70.45M 62.08M 63.1M 63.12M

Switzerland

620M 679M - - -

Executive Committee: DocMorris AG

Manager TitleAgeSince
Chief Executive Officer 61 2022-04-27
Director of Finance/CFO 56 2024-09-30
Chief Tech/Sci/R&D Officer - 2024-10-31
Chief Operating Officer 58 2022-10-31
Investor Relations Contact - 2022-07-31

Composition of the Board of Directors: DocMorris AG

Director TitleAgeSince
Chairman 68 2022-04-27
Chairman 71 2010-03-31
Director/Board Member 63 2019-05-22
Director/Board Member 53 2019-05-22
Director/Board Member 56 2020-12-31
Director/Board Member 46 2021-12-31

Shareholders: DocMorris AG

NameEquities%Valuation
13.12 %
6,706,658 13.12 % 40 M CHF
UBS Asset Management Switzerland AG
9.808 %
5,013,602 9.808 % 30 M CHF
6.868 %
3,510,712 6.868 % 21 M CHF
Astaris Capital Management LLP
4.651 %
2,377,489 4.651 % 14 M CHF
Swisscanto Fondsleitung AG
4.56 %
2,330,973 4.56 % 14 M CHF

Holdings: DocMorris AG

NameEquities%Valuation
3,510,712 6.87% 21 M $

Company details: DocMorris AG

DocMorris Ltd.

Walzmuehlestrasse 60

8500, Frauenfeld

+

http://corporate.docmorris.com
address DocMorris AG(ROSE)

Group companies: DocMorris AG

NameCategory and Sector
Finance/Rental/Leasing
Finance/Rental/Leasing

Other Drug Retailers

Change 5d. change 1-year change 3-years change Capi.($)
+9.76%+28.86%-63.45%-80.88% 408M
+0.78%-4.80%+38.16%-14.47% 19.87B
+0.85%+2.16%+3.72%-16.99% 9.7B
-0.08%-4.63%-8.93%-1.94% 5.95B
+3.28%+1.26%-21.02%+16.90% 4.34B
+1.51%-0.04%-19.70%-25.44% 3.99B
-1.30%+1.81%-6.65%-40.38% 3.74B
+0.81%-1.30%+2.69%-41.47% 2.91B
+1.18%-0.39%-1.53%+9.58% 2.86B
0.00%-4.77%+61.81% - 2.38B
Average +1.53%+1.81%-1.49%-21.68% 5.62B
Weighted average by Cap. +0.85%-1.55%+11.95%-14.30%
Trader
Investor
-
Global
-
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
9
Last Close Price
6.610CHF
Average target price
7.494CHF
Spread / Average Target
+13.37%

Quarterly revenue - Rate of surprise